Zydus recalls over 55k bottles of generic drug in US

USFDA said the company is recalling the product due to "failed impurities/ degradation specifications". An out-of-specification (OOS) result was observed during release testing of one lot for a related substance, i.e. Beta-lumicolchicine, it added. Zydus commenced the Class III recall on February 24 this year.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/LK65Xm2
via IFTTT